Одномоментная комбинированная технология лечения ретиноваскулярного макулярного отека «Macular double block»

    1. Шадричев Ф.Е., Шкляров Е.Б., Григорьева Н.Н. Использование анти-VEGF-терапии в лечении диабетического макулярного отека // Офтальмологические ведомости. – 2011. – Т. 4, № 1. – С. 83-93.

    2. Патент РФ № 2527360. Способ комбинированного лечения ретиноваскулярного макулярного отека / Исмаилов М.И., Агмадов А.М.; Заявитель и патентообладатель ГБОУ «Дагестанская государственная медицинская академия» Минздрава России; Заявл. 23.04.2013 г.; Опубл. 27.08.2014 г. // Бюл. – 2014. – № 24. – 9 с.

    3. Bughi S., Shaw S., Bessman A. Laser damage to retinal ganglion cells. The effect on circadian rhythm // J. Diabetes Complicat. – 2006. – Vol. 20. – P. 184-187.

    4. Campochiaro P.A., Hafiz G., Shah S.M. et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator // Mol. Ther. – 2008. – Vol. 16. – P. 791-799.

    5. Denton R., McCormie J. Calcium ions, hormones and mitochondrial metabolism // Clin. Seien. – 1981. – Vol. 61, № 2. – P. 35-40.

    6. Desmettre T., Maurage C. Transpupillary thermotherapy (TTT) with short, duration, laser exposures induce; heat shock protein; hyperexpression on choroidoretinal layers // Lasers Surg. Med. – 2003. – Vol. 33. – P. 102-107.

    7 Elman M.J., Aiello L.P. et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema // Ophthalmology. – 2010. – Vol. 117. – P. 1064-1077.

    8 Elsner H., Porksen E., Klatt C. et al. Selective retina therapy in patients with central serous chorioretinopathy // Graefes Arch. Clin. Exp. Ophthalmol. – 2006. – Vol. 244. – P. 1638-1645.

    9 Figueira J., Khan J., Nunes S. et al. Prospective randomised controlled trial comparing sub-threshold micropulse diode laser photocoagulation and conventional green laser for clinically significant diabetic macular oedema // Br. J. Ophthalmol. – 2009. – Vol. 93, № 10. – P. 1341-1344.

    10 Figueroa M.S., Ruiz Moreno J.M. BRAVO and CRUISE: ranibizumab for the treatment of macular edema secondary to retinal vein occlusion // Arch. Soc. Esp. Oftalmol. – 2012. – Vol. 87, № 1. – P. 46-53.

    11 Framme C., Brinkmann R., Birngruber R., Roider J. Autofluorescence imaging after selective RPE laser treatment in macular diseases and clinical outcome: a pilot study // Br. J. Ophthalmol. – 2002. – Vol. 86. – P. 1099-1106.

    12 Framme C., Walter A., Prahs P. et al. Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral domain OCT // Curr. Eye Res. – 2009. – Vol. 34. – P. 568-579.

    13 Friberg T. Infrared micropulsed laser treatment for diabetic macular edema – Subthreshold versus threshold lesions // Semin. in Ophthalmol. – 2001. – Vol. 16, № 1. – P. 19-24.

    14 Gupta N., Mansoor S., Sharma A. et al. Diabetic retinopathy and VEGF // Open Ophthalmol. J. – 2013. – Vol. 7. – P. 4-10.

    15 Kaufman S.C., Ferris F.L., Seigel D.G. et al. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. DRS Report Number 13 // Invest. Ophthalmol. Vis. Sci. – 1989. – Vol. 30. – P. 23-28.

    16 Koss M.J., Beger I., Koch F.H. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy // Eye (Lond). – 2012. – Vol. 26, № 2. – P. 307-314.

    17 Laursen M., Moeller F. Subthreshold micropulse diode laser treatment in diabetic macular oedema // Br. J. Ophthalmol. – 2004. – Vol. 88, № 9. – P. 1173-1179.

    18 Lavinsky D., Cardillo J.A., Melo L.A. et al. Randomized clinical trial evaluating mETDRS versus normal or high-density micropulse photocoagulation for diabetic macular edema // Invest. Ophthalmol. Vis. Sci. – 2011. – Vol. 52, № 3. – P. 4314-4323.

    19 Luttrull J.K., Spink C.J. Serial optical coherence tomography of subthreshold diode laser micropulse photocoagulation for diabetic macular edema // Ophthalmic Surg. Lasers Imaging. – 2006. – Vol. 37, № 5. – P. 370-377.

    20 Nakamura Y., Mitamura Y., Ogata K. et al. Functional and morphological changes of macula after subthreshold micropulse diode laser photocoagulation for diabetic macular edema // Eye (Lond). – 2010. – Vol. 24, № 5. – P. 784-788.

    21 Olk R.J., Akuduman L. Minimal intensity diode laser (810 nm) photocoagulation (MIP) for diffuse diabetic macular edema (DDME) // Semin. Ophthalmol. – 2001. – Vol. 16. – P. 25-30.

    22 Paulus Y., Jain A., Nomoto H. et al. Selective retinal therapy with microsecond exposures using a continuous line scanning laser // Retina. – 2011. – Vol. 31. – P. 380-388.

    23 Pece A., Isola V., Piermarocchi S., Calori G. Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-year follow-up // Brit. J. Ophthalmol. – 2011. – Vol. 95. – P. 56-68.

    24 Roider J., Brinkmann R., Wirbelauer C. et al. Retinal sparing by selective retinal pigment epithelial photocoagulation // Arch. Ophthalmol. – 1999. – Vol. 117. – P. 1028-1034.

    25 Roider J., Michaud N.A., Flotte T.J. et al. Response of the retinal pigment epithelium to selective photocoagulation // Arch. Ophthalmol. – 1992. – Vol. 110. – P. 1786-1792.

    26 Scott I.U., Ip M.S., VanVeldhuisen P.C. et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6 // Arch. Ophthalmol. – 2009. – Vol. 127. – P. 1115-1128.

    27 Stewart M.W., Rosenfeld P.J. Predicted biological activity of intravitreal VEGF Trap // Br. J. Ophthalmol. – 2008. – Vol. 92, № 5. – P. 667-668.

    28 Zhang X., Bao S, Lai D et al. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas // Diabetes. – 2008. – Vol. 57, № 4. – P. 1026-1033.